Upsher-Smith Urges High Court To Hear K-Dur Antitrust Case
Upsher-Smith Laboratories Inc. on Wednesday became the second defendant to ask the U.S. Supreme Court to review the Third Circuit's ruling that pay-for-delay pharmaceutical patent settlements are presumptively anti-competitive, telling the...To view the full article, register now.
Already a subscriber? Click here to view full article